CPRX
NASDAQ
US
Catalyst Pharmaceuticals, Inc. - Common Stock
$24.69
▼ $-0.13
(-0.52%)
Vol 616K
12
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$2.9B
P/E
13.2
ROE
26.4%
Margin
37.6%
D/E
0.00
Beta
0.74
52W
$19–$27
Wall Street Consensus
14 analysts · Apr 20267
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
92.9%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.34 | $0.41 | +$0.07 |
| Sep 2025 | $0.34 | $0.42 | +$0.08 |
| Jun 2025 | $0.39 | $0.41 | +$0.02 |
| Mar 2025 | $0.35 | $0.45 | +$0.10 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $141.8M | $141.4M | $146.6M | $148.4M | $152.6M |
| Net Income | — | $55.9M | $56.7M | $52.1M | $52.8M | $52.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 27.5% | 27.5% | 27.5% | 27.5% | 26.4% | 26.4% |
| P/E (TTM) | 12.67 | 11.90 | 12.18 | 12.48 | 12.80 | 13.18 |
| Net Margin | 35.5% | 37.4% | 37.4% | 37.4% | 37.6% | 37.6% |
| Gross Margin | 85.9% | 85.8% | 85.8% | 85.8% | 85.7% | 85.7% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.71 | 6.71 | 6.71 | 6.71 | 6.62 | 6.62 |
Key Ratios
ROA (TTM)
23.0%
P/S (TTM)
4.96
P/B
3.4
EPS (TTM)
$1.72
CF/Share
$0.77
Rev Growth 3Y
+51.7%
52W High
$26.58
52W Low
$19.05
$19.05
52-Week Range
$26.58
Financial Health
Free Cash Flow
$44.9M
Net Debt
-$706.4M
Cash
$709.2M
Total Debt
$2.8M
As of Dec 31, 2025
How does CPRX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
CPRX valuation vs Biotechnology peers
P/E ratio
13.2
▼
30%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
5.0
▼
61%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
3.4
▲
39%
above
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
CPRX profitability vs Biotechnology peers
ROE
26.4%
▲
139%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
37.6%
▲
113%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
85.7%
▲
9%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
23.0%
▲
149%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
CPRX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.6
▲
49%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
0.7
▼
23%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
CPRX fundamentals radar
CPRX
Peer median
Industry
CPRX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CPRX vs peers: key metrics
Related Signals
Latest News
No related news yet